Search results
Added:
2 years ago
Added:
2 years ago
Martin, María, et al. European Cardiology Review 2021; 16:e35. DOI:https://doi.org/10.15420/ecr.2021.09
View more
Added:
3 years ago
Dr Federico M Asch (MedStar Health Research Institute, Georgetown University, Washington DC, WA, US) discusses the latest findings from the Global EXPAND Study. Their research looked into mitral valve leaflet events with MitraClip (NTR/XTR).
Questions:
1. Can you briefly remind us what the EXPAND registry is and what it assesses?
2. What research have you conducted on leaflet adverse…
View more
Added:
3 years ago
Transcatheter aortic valve implantation (TAVI) is the therapy of choice for patients with symptomatic severe aortic stenosis who are unsuitable for surgical aortic valve replacement and for elderly patients with high operative risk.1,2 It is also considered to be a more than valid and reasonable alternative to surgical aortic valve replacement for patients with moderate to high surgical risk.3,4…
View more
Added:
3 years ago
Background
Echocardiography has evolved into the most predominant diagnostic imaging technique in cardiology. Over the last five decades the diagnostic capability of echocardiography has increased dramatically from M-mode to two-dimensional (2-D) imaging. Recent advances in ultrasound instrumentation and computer technology have led to three-dimensional (3-D) echocardiography, introducing a new…
View more
Added:
3 years ago
Progressive thickening of the aortic valve leaflets and narrowing of the aortic annulus leads to increased mechanical stress on the left ventricle and reduces cardiac output, resulting in further complications.1–3 The proportion of the population affected increases as the median age of a country or region rises. Approximately 2–4 % of people aged over 65 will develop calcific aortic stenosis,…
View more
Added:
3 years ago
Abstract
Mitral regurgitation (MR) is the most commonly found valvular lesion in echocardiography laboratories. Moderate and severe mitral regurgitation have proven to be associated with increased morbidity and mortality, and surgical reconstruction is recommended in severe cases whenever feasible. Three-dimensional echocardiography (3DE) is superior to conventional echocardiography in the…
View more
Added:
2 years ago
In this short interview, Dr Duk-Woo Park (Asan Medical Center, KR) discusses the findings from the ADAPT-TAVR Randomized Clinical Trial (NCT03284827).
The trial investigated Edoxaban versus dual antiplatelet therapy for leaflet thrombosis and cerebral thromboembolism after TAVR.
Presented first at ACC.22, ADAPT-TAVR shows that the overall incidence of leaflet thrombosis on CT scans was less…
View more
Added:
3 years ago
Despite the absence of randomised comparison, it is widely accepted that, when feasible, valve repair is the optimal surgical treatment in patients with severe degenerative mitral regurgitation (MR) due to the well documented advantages of such an approach over valve replacement in terms of perioperative mortality, preservation of postoperative left ventricular (LV) function and long-term…
View more
Added:
3 years ago
Non-invasive imaging of the heart continues to evolve and improve. Cardiovascular ultrasound (echocardiography) continues to play an important role in the diagnosis and assessment of responses to therapy of many cardiac conditions. Even as the clinical applications of newer techniques such as cardiac computed tomography (CT) and cardiac magnetic resonance imaging (CMRI) increase, the role of…
View more
